share_log

中國中藥:(I)修訂現有總採購協議之年度上限;及 (II)更新有關該等新總協議之持續關連交易

TRAD CHI MED: (I) REVISION OF ANNUAL CAP IN RELATION TO THE EXISTING MASTER PURCHASE AGREEMENT; AND (II) RENEWAL OF CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE NEW MASTER AGREEMENTS

Nov 11, 2022 09:26
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more